期刊文献+

TRF1在食管鳞癌中的表达及意义 被引量:3

Expressions of TRF1 as well as their clinical significance in esophageal squamous cell carcinomas
暂未订购
导出
摘要 目的探讨端粒重复序列结合因子1(Telomeric repeat binding factor 1,TRF1)在食管病变中的表达及其临床意义。方法采用免疫组化ABC法检测60例食管鳞状细胞癌、30例食管上皮内瘤变和20例食管正常组织中TRF1的表达,并探讨与食管癌临床病理特征之间的关系。结果在正常上皮组织、上皮内瘤变和食管鳞癌组织中,TRF1的阳性表达率分别为为95%、63.3%和21.7%。食管鳞癌组织中,TRF1的表达与浸润深度和肿瘤长度呈负相关(0>rs>-1,P<0.05)。结论TRF1在食管癌组织中表达异常降低,提示TRF1与食管癌的发生、发展有密切的关系,检测TRF1的表达可能成为判断食管鳞癌生物学行为的重要指标。 Objective To investigate the expressions of Telomeric repeat binding factor 1 ( TRF1 ) in esophageal squamous cell carcinomas (ESCC) and their clinical significance. Methods The expressions of TRF1 were detected by the immunohistochemical method in 60 cases of esophageal squamous cell carcinomas ( ESCC), 30 intraepithelial neoplasia and 20 normal esophageal mucosal epithelia. It's relations with the clinicopathologic features of ESCC were analyzed. Results The rates of positive expressions of TRF1 in normal esophageal mucosal epithelium, intraepithelial neoplasia and ESCC were respectively 95% ,63.3% and 21.7%. The expressions of TRF1 were negatively correlated with the depth of tumor invasion and the length of tumer in ESCC (0 〉 rs 〉 - 1,P 〈 O. 05). Conclusions Low expres- sion of TRF1 were found in ESCC. It may play an important role in the carcinogenesis and aggression in ESCC. TRF1 may be a useful marker for evaluating the biological behaviors of ESCC.
出处 《医学信息(内.外科版)》 2009年第5期441-444,共4页 Medical Information Operations Sciences Fascicule
基金 皖南医学院中青年科学基金(WK200701F)
关键词 端粒重复序列结合因子1 免疫组织化学 食管鳞癌 telomeric repeat binding factor 1 (TRF1) immunohistochemistry esophageal squamous cell carcino- mas (ESCC)
  • 相关文献

参考文献6

二级参考文献48

  • 1Chong L,van Steensel B,Broccoli D,et al.A human telomeric protein.Science,1995,270:1663-1667.
  • 2Smith S,Giriat I,Schmitt A,et al.Tankyrase,a poly(ADP-ribose)polymerase at human telomeres.Science,1998,282:1484-1487.
  • 3van Steensel B,de Lange T.Control of telomere length by the human telomeric protein TRF1.Nature,1997,385:740-743.
  • 4Yamada K,Yagihashi A,Yamada M,et al.Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cells.Anticancer Res,2002,22:1315-1320.
  • 5Ohyashiki JH,Hayashi S,Yahata N,et al.Impaired telomere regulation mechanism by TRF1 (telomere-binding protein),but not TRF2 expression,in acute leukemia cells.Int J Oncol,2001,18:593-598.
  • 6Januszkiewicz D,Wysoki J,Lewandowski K,et al.Lack of correlation between telomere length and telomerase activity and expression in leukemic cells.Int J Mol Med,2003,12:935-938.
  • 7Seimiya H,Smith S.The telomeric poly(ADP-ribose) polymerase,tankyrase 1,contains multiple binding sites for telomeric repeat binding factor 1 (TRF1) and a novel acceptor,182-kDa tankyrase-binding protein (TAB182).J Biol Chem,2002,277:14116-14126.
  • 8Chi NW,Lodish HF.Tankyrase is a golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles.J Biol Chem,2000,275:38437-38444.
  • 9Smith S,de Lange T.Cell cycle dependent localization of the telomeric PARP,tankyrase,to nuclear pore complexes and centrosomes.J Cell Sci,1999,112:3649-3656.
  • 10Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats[J].Cell, 1989, 59(3): 521-529.

共引文献12

同被引文献25

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部